Bruntwood SciTech on course to build £210 m tech campus
Bruntwood SciTech has received planning permission for its £210m Birmingham Health Innovation Campus.
No 1 Birmingham Innovation Campus, the first phase of the development, will offer 133,000 sq ft of lab and office space designed for health innovation and life sciences businesses.
Focusing on companies working in medtech, precision medicines, biopharma and digital healthcare, the building will include the home of the University of Birmingham’s Precision Health Technologies Accelerator (PHTA).
Bruntwood’s 10-year masterplan will provide up to 657,000 sq ft of state-of-the-art space for the life sciences sector, supporting the creation of more than 10,000 new jobs and contributing an estimated £400m of GVA to the regional economy by 2030.
David Hardman, managing director of Bruntwood SciTech Birmingham, said the development marks a “real milestone” in the region’s evolution as a healthtech powerhouse. He added: “The region has all the raw ingredients the sector needs – world-class universities, a number of specialist NHS Trusts, quality infrastructure and a growing cluster of SMEs – to support the journey from early R&D to manufacture and market adoption of new health products and services.
“The Campus will be the epicentre where all these come together and attract further inward investment to ensure the West Midlands has one of the country’s most exciting life sciences propositions for years to come.”
Birmingham Health Innovation Campus is being built in Selly Oak, in the heart of the University of Birmingham’s academic and clinical cluster with the first phase set to complete in 2023.
Tim Pile, chair of Greater Birmingham and Solihull Local Enterprise Partnership, said: “Healthcare innovation has been under the spotlight over the last 12 months and Birmingham Health Innovation Campus will undoubtedly help address the health needs that have emerged throughout Covid-19.”